Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study-Focus on Formulation in Children

• Hauptverfasser: Sissel Sundell Haslund-Krog (Verfasst von), Inger Merete Jørgensen (Verfasst von), Kim Dalhoff (Verfasst von), Helle Holst (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2022-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Developing acceptable medicines for children is a complicated task. Several factors must be considered, including age, physiology, texture preference, formulation, and legal framework among others. In the development of new paediatric medicines, these factors are assessed. However, for older medicin...